Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
about
Ventricular metastasis resulting in disseminated intravascular coagulationProcoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo.Whole blood procoagulant activity in breast and colorectal cancerBronchogenic adenocarcinoma presenting as a synchronous solitary lytic skull lesion with ischaemic stroke--case report and literature reviewCharacterization of factor XIII containing-macrophages in lymph nodes with Hodgkin's diseaseIncreased thromboembolic incidence in anti-cardiolipin-positive patients with malignancyTissue factor activity of SW-480 human colon adenocarcinoma cells is modulated by thrombin and protein kinase C activation.Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis.Coagulopathy in the prostate cancer patient: prevalence and clinical relevance.A factor X-activating cysteine protease from malignant tissueExpression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.Acute disseminated intravascular coagulation following surgical resection of a myeloid sarcoma in a 57-year-old male.The Pathogenetic Role of Apoptosis in Hypercoagulable States.Development and validation of an assay for urinary tissue factor activity.Malignancy and haemostasis.New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver.FIBRIN AND FIBRINOGEN DEGRADATION PRODUCTS IN MALIGNANCY.Factor X-activating activity from Lewis lung carcinoma.Augmentation of antimetastatic activity of interferon and tumor necrosis factor by heparin.Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia.Coagulation and cancer.Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.
P2860
Q24811669-F1743AB4-8658-4D7E-908D-311CF07E5DEFQ33490882-1DD35C74-41E6-465E-823A-2EC69B7F4A3BQ33840071-E0F0E239-8C13-44E8-BB58-1A1BD134744CQ35634392-D68EE2F1-B8B4-4494-9E6E-FFCFA5578A01Q36027949-E13ED10B-353D-41AC-84F3-E0DC56DE9C54Q36081533-86FC48B5-9DB6-4586-8FD7-CCF95032D4A5Q36115096-990E9048-9927-4E76-85C9-85D655624F54Q36466633-0717F540-17AB-4F89-B7CA-BBFA2BD2B7DEQ36618251-362720DB-1F87-4A71-9181-FACBC9C79DF7Q36814099-5E2D94CE-9778-48BC-AE41-7614C87E7FCAQ36999974-6710BC8E-B015-46C6-B5CD-C7F07FFCB1C8Q37341182-B58BAF8A-42A5-456E-A99F-B3177992AFF8Q37694269-D44240FD-E599-4C0A-936F-228CCB8AAA12Q38897750-48A8AE85-4758-414A-BEBD-A958DCB29A0EQ39607876-14F033E0-48CA-409C-8124-6A9813A005F0Q40284052-7A8F555B-C29B-4738-AA96-D5E45524A6F4Q40771484-090C0589-1E67-413D-B8CA-41A444ABC04AQ41090311-4012E69A-DF00-49A8-972E-BD5B2C390910Q41145626-17619B5B-74B4-4547-B345-67F670E127D0Q41477040-9FA0FB3F-AB44-48C5-B1D7-8514432ED824Q41754659-53C86922-F8B8-495B-A22A-6494D3FD1755Q42007941-34B33FD4-FCEF-4E91-A7B8-2CA13DEED956Q42137618-0FC6E6FD-C7A7-41F1-BC1A-3C3EFB8FD550Q42372251-6453B7EF-49E8-4F1E-9052-4C52C4106991Q42389635-0484B162-085A-4E4A-AD14-7C92150C63CF
P2860
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
@en
type
label
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
@en
prefLabel
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
@en
P2093
P1433
P1476
Cancer procoagulant A: a factor X activating procoagulant from malignant tissue.
@en
P2093
P304
P356
10.1016/0049-3848(75)90018-3
P577
1975-02-01T00:00:00Z